HomeALM • VIE
add
Almirall SA
Previous close
€12.52
Day range
€12.48 - €12.58
Year range
€8.09 - €12.78
Market cap
2.68B EUR
Avg Volume
4.00
P/E ratio
124.32
Dividend yield
1.47%
Primary exchange
BME
Market news
FXStreet
13 minutes ago
Equity euphoria meets the fear reawakening: Nasdaq and S&P 500 near exhaustion
0.26%
0.20%
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 277.27M | 10.35% |
Operating expense | 232.48M | 12.88% |
Net income | 4.98M | -37.68% |
Net profit margin | 1.80 | -43.40% |
Earnings per share | — | — |
EBITDA | 39.04M | -25.03% |
Effective tax rate | 40.20% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 323.22M | -2.31% |
Total assets | 2.31B | -0.58% |
Total liabilities | 844.82M | 1.20% |
Total equity | 1.46B | — |
Shares outstanding | 214.79M | — |
Price to book | 1.84 | — |
Return on assets | 0.95% | — |
Return on capital | 1.21% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 4.98M | -37.68% |
Cash from operations | 31.15M | -27.41% |
Cash from investing | -58.13M | 16.98% |
Cash from financing | -24.47M | -212.31% |
Net change in cash | -51.45M | -47.23% |
Free cash flow | -87.74M | -11.43% |
About
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Founded
1944
Website
Employees
2,084
